Identifying genetic markers for Brugada Syndrome diagnosis
Official title: Unveiling the Genetic Landscape of Brugada Syndrome: Novel Biomarker Discovery for Precise Diagnosis
Run by IRCCS Policlinico S. Donato · NCT06647927 · Data updated 2026-11-12
This study is testing if new genetic tools can help doctors better diagnose Brugada Syndrome and create more personalized treatment plans for patients.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 350 (estimated) |
| Sponsor | IRCCS Policlinico S. Donato Academic / other |
| Locations | 1 site (San Donato Milanese, Milan) |
| Status | Recruiting |
| Started | December 2, 2024 |
| Main results expected | May 2026 |
| Study ends | September 2026 |
| Registry record updated | May 14, 2025 |
| Trial ID | NCT06647927 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults over 18 years old who have been diagnosed with Brugada Syndrome.
✕Probably not a fit
Patients who do not have Brugada Syndrome or are under 18 years old will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This research focuses on improving the diagnosis of Brugada Syndrome (BrS) through advanced genetic sequencing techniques. By developing a genetic signature and identifying specific biomolecular profiles, the study aims to enhance understanding of the syndrome's molecular mechanisms. The approach includes a multi-omic strategy that integrates whole-exome sequencing and machine learning to uncover altered pathways related to BrS. The ultimate goal is to facilitate personalized treatment plans and refined risk assessment for patients affected by BrS.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and efficient diagnoses of Brugada Syndrome, enabling better-targeted therapies.
How similar studies have gone: Other studies have shown promise in using genetic sequencing for diagnosing cardiac conditions, suggesting potential success for this approach in Brugada Syndrome.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \> 18 years * Patients affected by Brugada Syndrome * Patients who signs the Informed Consent Exclusion Criteria: * None
Where it's running
-
Irccs Policlinico San Donato
San Donato Milanese, Milan, Italy Recruiting
Study contacts
- Study coordinator: Giuseppe Ciconte MD, PhD
- Email: Giuseppe.Ciconte@grupposandonato.it
- Phone: +390252774260
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Perioperative risks in adults with Brugada syndrome during anesthesia and related procedures
This registry follows adults with Brugada syndrome to see how often dangerous heart rhythms occur around anesthesia and up to 30 days after.
-
Detecting hidden heart rhythm disorders using wearable ECG technology
This study is testing whether wearable heart monitors can help find hidden heart rhythm problems, specifically Brugada syndrome, in people who might not know they have it.
-
Claudin-2 Immunostaining to Detect Active or Inactive Inflammation in IBD Biopsies
This study tests whether staining for Claudin-2 in intestinal biopsy samples can help identify active vs. inactive inflammation in people with ulcerative colitis or Crohn's disease.
-
Using 4D Flow MRI to characterize left ventricular failure
This project will test whether automated 4D Flow MRI analysis can measure left ventricular dysfunction in adults with severe aortic stenosis who are scheduled for TAVR.
-
Measuring aortic wall strength and thickness in ascending aortic aneurysms
This project tests whether measuring the strength and thickness of removed ascending aortic tissue can help predict rupture risk for patients having surgery for aortic root or ascending aortic aneurysms.
-
Finding signs of Alzheimer's in people with subjective memory complaints
The study will test whether inexpensive, easy-to-get measures—like blood markers, EEG and automated speech analysis—can help identify early Alzheimer's in people who notice memory or thinking changes but have normal standard tests.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.